VANESSA LODIN MONTANARI
Vanessa Lodin Montanari: background and expertise
Vanessa Lodin Montanari is the founder and managing director of Pharmaspecific, a French clinical research company founded in 2010. A life sciences entrepreneur, she has more than 20 years of experience in international clinical research, quality and pharmaceutical operations.
Her expertise covers supporting sponsors and investigators, overseeing clinical trials, developing manufacturing sites compliant with Good Manufacturing Practice (GMP) and managing international projects in highly regulated environments.
She holds a master’s degree in cell biology and physiology, a university diploma in statistical methodology applied to clinical research and a Clinical Research Associate certification, and has worked with a number of players in the pharmaceutical sector, CROs and research institutions.
These organisations include ABBOTT, PPD Inc., Gustave Roussy Institute and the European Association for Research in Oncology.
Over the course of her career, Vanessa Lodin Montanari has contributed to national, European and international therapeutic projects, including Phase II, III and IV clinical trials and epidemiological studies.
Clinical research expertise and regulatory compliance
As a clinical research expert, Vanessa Lodin Montanari works in auditing, quality management, pharmacovigilance and computerised systems validation.
At Pharmaspecific, she also acts as a GCP auditor, contributing to the regulatory compliance and quality of clinical research activities.
She leads training courses and seminars for industry professionals and helps develop the skills of Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs) and research teams.
International commitment and awards
Committed to making international clinical research more accessible and responsible, Vanessa Lodin Montanari helps strengthen collaboration between Europe, Africa and the French overseas territories.
Her entrepreneurial career was recognised with the « Innovation & Society » award in 2019 at the Afro-Creole entrepreneurs competition.
In 2025, she was also named an Overseas Talent (Talent de l’Outre-mer) in the Established Talents category by CASODOM.
Through her leadership, auditing and training activities, the founder of Pharmaspecific continues her commitment to innovation, quality and skills development in clinical research.
ENTRUST YOUR CLINICAL OPERATIONS TO AN EXPERIENCED CRO
Our experts support you at every stage of your clinical study: regulatory submissions, monitoring, on-site coordination, patient reimbursement management and quality compliance.